First Manhattan’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-338
Closed -$5.33K 1081
2024
Q1
$5.33K Hold
338
﹤0.01% 1188
2023
Q4
$6.8K Sell
338
-11
-3% -$186 ﹤0.01% 1164
2023
Q3
$6.47K Sell
349
-659
-65% -$14.4K ﹤0.01% 1200
2023
Q2
$21.9K Sell
1,008
-2,680
-73% -$48.4K ﹤0.01% 1019
2023
Q1
$68.3K Sell
3,688
-25,226
-87% -$474K ﹤0.01% 870
2022
Q4
$440K Buy
28,914
+13,954
+93% +$199K ﹤0.01% 541
2022
Q3
$208K Buy
+14,960
New +$301K ﹤0.01% 684
2019
Q2
Sell
-4,000
Closed -$114K 1417
2019
Q1
$114K Hold
4,000
﹤0.01% 807
2018
Q4
$114K Buy
+4,000
New +$125K ﹤0.01% 776

Other funds holding NEOG

First Manhattan's NEOG Position: Q2 2024 in Review

First Manhattan sold out of Neogen (NEOG) in Q2 2024, closing a stake of 338 shares — an estimated $5.33K sold.

First Manhattan first reported a position in NEOG in Q4 2018 and held it in 9 quarters. The position peaked at $440K in Q4 2022. 345 funds tracked by Wall St. Rank hold NEOG as of Q2 2024.

  • First Manhattan reported no remaining Neogen position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 338 Neogen shares in Q2 2024, an estimated $5.33K.
  • First Manhattan first reported a position in Neogen in Q4 2018 and held it in 9 quarters.
  • First Manhattan's Neogen position peaked at $440K in Q4 2022.
  • 345 funds tracked by Wall St. Rank held Neogen as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.